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Summary
Spatiotemporal regulation of mitotic kinase activity underlies the extensive rearrangement of cellular components required for cell
division. One highly dynamic mitotic kinase is Aurora-B (AurB), which has multiple roles defined by the changing localisation of the
chromosome passenger complex (CPC) as cells progress through mitosis, including regulation of cytokinesis and abscission. Like other
mitotic kinases, AurB is a target of the anaphase-promoting complex (APC/C) ubiquitin ligase during mitotic exit, but it is not known if
APC/C-mediated destruction plays any specific role in controlling AurB activity. We have examined the contribution of the Cdh1
coactivator-associated APC/CCdh1 to the organization of AurB activity as cells exit mitosis and re-enter interphase. We report that APC/
CCdh1-dependent proteolysis restricts a cell-cortex-associated pool of active AurB in space and time. In early G1 phase this pool of AurB
is found at protrusions associated with cell spreading. AurB retention at the cortex depends on a formin, FHOD1, critically required to
organize the cytoskeleton after division. We identify AurB phosphorylation sites in FHOD1 and show that phosphomutant FHOD1 is
impaired in post-mitotic assembly of oriented actin cables. We propose that Cdh1 contributes to spatiotemporal organization of AurB
activity and that organization of FHOD1 activity by AurB contributes to daughter cell spreading after mitosis.
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Introduction
Cells preparing to divide undergo extensive rearrangement of the
cytoskeleton that include loss of integrin-mediated adhesion,
disassembly of actin structures and cell rounding (Kunda and
Baum, 2009). As cells exit mitosis to return to interphase these
processes are reversed. Very little is known about how such
events are regulated, but in common with other steps of mitotic
exit, they are assumed to require reversals of specific mitotic
phosphorylation events that depend on upregulation of
phosphatase activity and/or inactivation of mitotic kinases
(Wurzenberger and Gerlich, 2011).
Ubiquitin-mediated proteolysis is one route to inactivation of
mitotic kinases. The anaphase-promoting complex (APC/C)
ubiquitin ligase targets a large number of substrates at mitotic
exit (Pines, 2011) including mitotic kinases that play essential
roles during mitotic exit, most notably Plk1 and AurB (Lindon
and Pines, 2004; Stewart and Fang, 2005). Perturbing degradation
of these kinases perturbs mitotic exit (Floyd et al., 2008; Lindon
and Pines, 2004; Stewart and Fang, 2005), consistent with the
idea that ubiquitin-mediated proteolysis can contribute to
dynamic spatial redistribution of kinase activity through
targeting of specific subpopulations (Lindon, 2008).
The multiple essential roles of AurB require repeated
relocalisation of the kinase during mitosis (Carmena and
Earnshaw, 2003). AurB is the enzymatic core of the CPC and
depends on other members of the complex (notably INCENP) for
localisation and activity. At anaphase CPC relocalises to the
spindle midzone, with AurB playing critical roles in promoting
assembly of the midzone and in signalling to the equatorial cortex
to trigger cytokinesis (Douglas et al., 2010; Hu¨mmer and Mayer,
2009). After anaphase the spindle midzone is compacted into the
midbody matrix and AurB activity at the midbody regulates
timing of abscission (Steigemann et al., 2009). AurB has specific
target interactors and substrates during mitotic exit, including
known regulators of cytokinesis and abscission (Bastos et al.,
2012; Capalbo et al., 2012; Douglas et al., 2010; Neef et al.,
2006) and others identified via proteomic studies whose function
in mitotic exit is unknown (Ozlu¨ et al., 2010). One such interactor
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is the diaphanous-related formin (DRF), formin homology 2
(FH2) domain-containing protein 1 (FHOD1). Formins nucleate
actin filaments by stabilizing actin dimers through the conserved
FH2 domain and promote their elongation by capping the barbed
end of growing filaments. DRFs have also been found to regulate
microtubule (MT) dynamics independent of their actin nucleation
function (Bartolini et al., 2008; Cheng et al., 2011) and
are increasingly recognized as mediators of interactions between
MT and actin cytoskeletons (Bartolini and Gundersen, 2010;
Chesarone et al., 2010).
In addition to specific roles for AurB in promoting mitotic exit,
pathways attenuating AurB activity are also required for different
steps in mitotic exit (Ramadan et al., 2007; Sumara et al., 2007;
Va´zquez-Novelle and Petronczki, 2010; Wurzenberger et al.,
2012). However, the targeted destruction of AurB by the APC/C
has not yet been shown to play any specific role in controlling
AurB activity during mitotic exit. Here we have tested the idea
that APC/C contributes to dynamic spatial organization of AurB
activity as cells return to interphase. We uncover a role for Cdh1-
dependent APC/C activity in controlling a subpopulation of AurB
that is recruited to the cell cortex in a FHOD1-dependent manner
in early G1 phase to play a role in promoting post-mitotic
spreading via FHOD1.
Results
APC/CCdh1 exerts spatial control on AurB kinase activity at
the end of mitosis
Previous studies have indicated that, at the end of mitosis, AurB
disappears from the cell later than other APC/C substrates (Floyd
et al., 2008; Lindon and Pines, 2004; Sigl et al., 2009), and
indeed in vivo time-lapse analysis of AurB–GFP degradation
reveals Cdh1-dependent proteolysis of AurB continuing over a
window of time that extends well into G1 phase (C.M., M.M. and
C.L., unpublished data). We wanted to test the idea that ongoing
AurB proteolysis contributes to the organization of mitotic exit.
Therefore we examined the distribution of AurB at early G1
phase in synchronized, fixed populations of human HeLa,
hTERT-RPE1 (RPE) and U2OS cells after brief treatment with
the proteasome inhibitor MG132 or after siRNA-mediated
silencing of Cdh1 expression (Fig. 1A–E; supplementary
material Fig. S1 and data not shown). As expected we found
most cellular AurB at the midbody, and in siRNA-treated (Cdh1-
i) cells there was also some accumulation of AurB in the nucleus.
In addition, we noticed in approximately half of MG132-treated
or Cdh1-i cells a small population of AurB localised at the edge
of the cell at sites distal to the midbody (Fig. 1A,B;
supplementary material Fig. S1). We confirmed that other CPC
components (INCENP, survivin) colocalised with AurB at these
sites (supplementary material Fig. S1). In some cells these sites
appeared to correspond to the cortical extremities of MTs
(Fig. 1A,E). In other cells AurB colocalised with actin-rich
structures (supplementary material Fig. S1), as previously
reported during monopolar cytokinesis (Hu et al., 2008) or in
cells overexpressing AurB–GFP (Abdullah et al., 2005),
indicating that AurB might be able to interact with either MTs
or F-actin at different times or under different conditions.
Next, we tested if this cortical pool of AurB contained active
kinase, using a phospho-specific antibody raised against AurB
phospho-T232 (pAur). The midbody stained strongly with pAur
antibody in most control and Cdh1-i cells. In addition we found
that the population of AurB at the cell cortex, but not that in the
nucleus, also stained with the pAur antibody (Fig. 1C). We
measured the intensity of staining with pAur and AurB antibodies
at different locations in the cell to obtain an estimate of relative
state of activity of AurB (Fig. 1D; supplementary material
Fig. S1). We found that whereas chromatin-associated AurB did
not stain with pAur, consistent with phosphatase-mediated
inactivation of this pool (Murnion et al., 2001; Vagnarelli et al.,
2011), relative AurB kinase activity at the cell edge in either
control or Cdh1-i cells appeared almost as high as in the
midbody. In conclusion, active AurB is present at the cell cortex
in early G1 phase and is readily detectable under conditions
where it is not degraded efficiently during mitotic exit.
We also found AurB at the cell cortex in a fraction of early G1
cells that had not been treated with Cdh1-i or MG132 (Fig. 1B).
This early G1 window (during which daughter cells remain
connected via a midbody-containing intercellular bridge) typi-
cally lasts an hour or more. Since even brief treatment with MG132
significantly increased the fraction of cells showing cortical AurB
we hypothesized that AurB localisation to the cell edge was a
transient event occurring in all early G1 phase cells. Indeed,
approximate staging of our populations of fixed cells indicated that
cortical AurB was systematically associated with ‘young’ G1 cells
but absent from those with a more mature intercellular bridge
(Fig. 1E). To test our hypothesis, we created a cell line expressing
Venus-tagged AurB under tight tetracycline control, suitable for
dynamic study of AurB localisation in living cells (Fig. 1F–H).
AurB–Venus mimicked faithfully the enrichment of endogenous
AurB to the cell edge seen in fixed populations of G1 phase cells
(Fig. 1G–H). Moreover, a version of AurB–Venus lacking the N-
terminal KEN motif (Nguyen et al., 2005) that is partially
stabilized during mitotic exit (C.M., M.M. and C.L., unpublished
data) was more frequently found in this localisation, confirming
that proteolysis of AurB–Venus defines the fraction of cells
showing cortical localisation of the kinase (Fig. 1H). In time-lapse
analyses of living cells we found that AurB–Venus did indeed
localise to the edge of the cell in a spatially and temporally
restricted manner. Cortical enrichments of AurB–Venus appeared
in almost every cell analysed (89.7%, n539), during a time
window beginning 1563 minutes after anaphase onset and lasting
for 3369 minutes (Fig. 1F; Fig. 2A; Table 1), and systematically
associated with protrusions of the cell cortex that occur during
post-mitotic spreading (supplementary material Movie 1).
Therefore AurB recruitment to the cell edge is an event that
occurs during a specific window of time during mitotic exit.
Localisation of AurB to the cell cortex is dependent on
MTs and the actin cytoskeleton
To define parameters involved in spatiotemporal regulation of
AurB in early G1 we examined the dynamics of AurB–Venus
localisation when proteolysis was inhibited, by adding MG132 to
cells during filming. We found that the timing of appearance of
AurB–Venus at the cell cortex was unchanged, but that the kinase
accumulated all along the spreading edge of early G1 cells
(Fig. 2B; supplementary material Movie 2) and persisted there,
frequently until the end of filming (§87621 minutes in MG132,
Fig. 2A; Table 1). We concluded that removal of the kinase from
the cell cortex is proteolysis-dependent. Next we examined the
role of cytoskeletal components in localising AurB to the cell
cortex. Treatment of cells with the MT depolymerizing drug
nocodazole shortly after anaphase onset prevented AurB–Venus
localisation to the cell cortex (Fig. 2A,B; supplementary material
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Movie 3). Consistently, treatment with the MT stabilizing agent
taxol induced strong accumulation of AurB–Venus on cortical
MT bundles (Fig. 2A,B). In contrast, disruption of F-actin by
treatment with cytochalasin D increased the persistence of AurB–
Venus spots visible near the cell edge (Fig. 2A,B). Inhibition of
Aurora B kinase activity by addition of the inhibitor ZM447439
(ZM) (Ditchfield et al., 2003) reduced recruitment of AurB–
Venus to the cell cortex (Fig. 2A), which could explain why
AurB is not seen at the cortex in MG132-treated interphase cells,
when it is not fully active. Together we interpreted these data to
mean that active AurB travels to the early G1 cell cortex on MTs
but is then removed from them in a manner that depends on
Fig. 1. See next page for legend.
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F-actin, and retained at the cortex in a manner limited by
ubiquitin-mediated proteolysis.
APC/CCdh1 regulates the actin cytoskeleton in early G1
phase through targeting of AurB
We investigated the role of the newly characterized cortical pool
of AurB in post-mitotic spreading of daughter cells, a process that
requires coordination of MT and actin networks in early G1
phase. We used RPE cells for this study, since these spread
rapidly after division, showing marked polarization in early G1
phase. For time-lapse observation of actin organization in living
cells we used Venus-tagged a-actinin to label the actin
cytoskeleton, allowing visualization of stress fibres (SFs), focal
adhesion complexes and other actin-rich structures (Edlund et al.,
2001). We generated a stable cell line, RPE-a-actinin–Venus, in
which daughter cells show strongly polarized spreading after
division, such that protrusive activity occurs at the furthest point
from the site of division (supplementary material Movie 4). This
protrusive activity usually establishes a single leading edge per
cell at a site distal to the intercellular bridge. Daughter cells then
migrate away from each other, typically with a persistent
directionality determined by the position of cleavage (Albrecht-
Buehler, 1977) that maximizes the distance between them during
early G1 (supplementary material Fig. S2). SFs become visible,
either as dorsal fibres behind the leading edge or as lateral
peripheral fibres, ,45 minutes after anaphase onset (Fig. 2C,D).
We treated RPE-a-actinin–Venus cells with MG132 shortly
after anaphase onset and found that proteolysis inhibition during
mitotic exit prevented polarized cell spreading and significantly
delayed re-assembly of SFs at the end of mitosis (Fig. 2C,D). At
least some of this effect was the result of stabilizing substrates of
APC/CCdh1 because we saw a similar effect in Cdh1-i cells.
Cdh1-i cells displayed continuous ruffling and short-lived
protrusions all around the edge of daughter cells, were slow to
adopt a polarized shape (Fig. 2C,E; supplementary material
Movie 5), failed to establish a clear leading edge and showed
reduced directionality in migration (supplementary material Fig.
S2). The timing of a-actinin–Venus recruitment to sites of
cortical activity and in focal adhesions appeared normal
(1765 minutes and 1865 minutes respectively, n516), while
the appearance of SFs was delayed (63.3623 versus 44.9611 for
control cells, P,0.01 by Student’s t-test; Fig. 2D). In particular
we observed in Cdh1-i cells an absence of SFs along the cell
periphery. We concluded that proteolysis of one or more Cdh1
targets contribute to reassembly of SFs and to polarized cell
shape at the start of interphase.
We then tested if one of these targets was AurB, by treating
control and Cdh1-i cells with ZM shortly after anaphase entry to
test if we could accelerate assembly of SFs through inhibition of
AurB. We found that ZM treatment did significantly accelerate
the appearance of SFs in control cells (Fig. 2C,D). In Cdh1-i
cells, however, this effect was less consistent and moreover loss
of cell shape was only partially rescued by AurB inhibition
(Fig. 2C–E). Instead, ZM treatment produced immediate pron-
ounced ruffling and extension of existing lamellipodia-like
protrusions (Fig. 2C, supplementary material Movie 6). It is
possible that ZM is added too late in these experiments to
influence cell polarity (it cannot be added earlier than late
telophase without causing cytokinesis to fail) and also likely that
the effects of Cdh1-i depend on additional targets, such as Rho
regulators p190rhoGAP and Ect2 (Liot et al., 2011; Naoe et al.,
2010). We also reasoned that cell-wide inhibition of AurB might
not be able to rescue effects on cell spreading that depend on
spatial organization of AurB activity.
AurB is recruited to the cell cortex by FHOD1
To understand more about the spatial organization of AurB in
mitotic exit we tested known AurB interactors that might
contribute to its distinctive localisation during mitotic exit.
These included the C-(cytokinesis)-phase-specific AurB interac-
tor FHOD1 (Ozlu¨ et al., 2010), which seemed a particularly
promising candidate for an interactor defining a distinct pool of
AurB, since in our experiments – unlike other documented
interactors – it appeared to be absent from the midbody.
Moreover, FHOD1 had previously been implicated in driving
cell elongation in human tissue culture cells (Gasteier et al.,
2005).
Fig. 1. Spatiotemporal control of AurB kinase activity by APC/CCdh1 in
early G1 phase. (A–D) Synchronized populations of HeLa cells were fixed
13 hours after release from thymidine/aphidicolin block and stained for AurB
and tubulin (A,B) or pAur and AurB (C,D). (A) Representative images of
cells treated for 15 minutes with 4 mM MG132. Enlarged images of the boxed
regions are shown in which the brightness and contrast have been adjusted to
reveal AurB at the cell cortex; all pixels within insets were treated in an
identical fashion. AurB appears to colocalise with MT tips in some areas
(arrow) but not in others (asterisks). (B) Quantification of AurB localisation in
early G1 cells of populations treated with GL2 (control) or Cdh1 siRNA, or
with MG132 as in A. Early G1 phase is defined as the window of time during
which daughter cells are attached by an AurB-positive midbody. At least 100
cells were scored for each condition in five or more separate experiments, and
mean values plotted as bar graphs with standard deviations (s.d.) shown.
*P,0.001, x2-test. (C) Representative images of siRNA-treated populations
stained for AurB and pAur. Enlarged images of the boxed regions are shown,
in which the brightness and contrast have been adjusted, and all pixels treated
in an identical fashion. Arrows indicate cortical pAur/AurB staining.
Specificity of pAur antibody is confirmed in supplementary material Fig. S1.
(D) Distribution of active AurB, using average pAur and AurB pixel values
measured in different regions of cells stained as in C, corrected for
background value adjacent to each cell. Upper panel shows distribution of
individual pAur values. Bar graphs show the ratio of pAur/AurB values
(means 6 s.d., normalized to the maximum value, which was set to 1.0) to
indicate the relative activity of each pool of AurB. See also supplementary
material Fig. S1. (E–H) Validation of AurB–Venus as a marker for a cortical
pool of AurB. (E) Approximate staging of untreated U2OS cells in early G1,
fixed and stained to reveal endogenous AurB. Enlarged images of the boxed
regions show AurB staining at the cell cortex in ‘younger’ daughter cells;
asterisks indicate midbodies of presumed ‘older’ daughters where no cortical
AurB is detectable. (F) Time-lapse fluorescence imaging of mitotic exit in
U2OS cell expressing AurB–Venus. Images are frames from supplementary
material Movie 1, shown as maximum intensity projections of 1 mm stacks,
with times adjusted to anaphase onset. Brightness and contrast have been
adjusted within the enlarged boxed regions, with each pixel of the inserts
treated in an identical fashion. Arrows on first of DIC series indicate the
position of retraction fibres at metaphase. See also Fig. 2A and Table 1.
(G,H) Comparison of AurB localisation in U2OS cells fixed and stained for
AurB as in E, with AurB–Venus localisation in U2OS-AurB–Venus cells
fixed and stained with GFP antibody. (G) AurB or GFP pixel values measured
in the cortical pool were expressed as a fraction of midbody or total
fluorescence, after correction for background pixel values. Bar graphs show
mean values 6 s.d. of ratios measured in at least 10 cells from two separate
experiments. (H) Localisation to the cell cortex of endogenous AurB in U2OS
cells and AurB–Venus-wt or AurB–Venus lacking the N-terminal KEN motif
AurB-Venus-nd in cell lines were scored as described in B. Scale bars:
20 mm.
Journal of Cell Science 126 (13)2848
J
o
u
rn
a
l
o
f
C
e
ll
S
c
ie
n
c
e
Fig. 2. Cdh1 and AurB kinase influence cell spreading in early G1. (A,B) U2OS-AurB–Venus cells were treated with the indicated drugs after anaphase onset
(doses in Materials and Methods) and recorded by time-lapse microscopy as in Fig. 1F. (A) Results from multiple experiments plotted as bars representing
trajectories of individual cells. A statistical summary of these data can be found in Table 1. (B) Frames from representative movies with times adjusted to
anaphase onset. Drug treatments occurred at the following times after anaphase for the cells shown: MG132 (13 minutes), nocodazole (noco; 8 minutes), taxol
(10 minutes), cytochalasin D (cytoD; 8 minutes). Brightness and contrast have been adjusted in the enlarged images of the boxed regions to show AurB
accumulation (or lack thereof) at the edge of the cell. Arrows indicate midbodies. (C) Representative frames from fluorescence time-lapse microscopy of non-
confluent cell cultures of RPE-a-actinin–Venus, with the appearance of a-actinin-associated structures scored by arrows (actin fibres) or arrowheads (leading
edges). The images on the right are enlargements of the 46 minutes time point. See supplementary material Movies 4–6. Drugs, as indicated, were added at the
following times after anaphase onset: MG132, 8 minutes; ZM, 10 minutes; Cdh1i/ZM, 17 minutes. (D) The timings of actin fibre assembly using time-lapse data
collected during two or more experiments and plotted as means 6 s.d. P-values were calculated using Student’s t-test. (E) Time-lapse movies of RPE-a-actinin–
Venus cells were used to measure the area of daughter cells during cell spreading (upper panel). Length of daughter cells was measured from midbody to cell edge
along the axis defined by the position of the anaphase spindle and a cell shape index calculated by expressing the cell area as a function of cell length (lower
panel). Distribution of measurements from individual cells are shown: elongated, polarized daughter cells give the lowest cell shape index. *P,0.01, **P,0.001,
Student’s t-test. Scale bars: 20 mm.
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The available antibody against FHOD1 did not recognize
endogenous FHOD1 by immunofluorescence but we found some
colocalisation of HA-tagged FHOD1 with AurB–Venus and
pAurB at sites at the cell periphery in early G1 phase (Fig. 3A).
After siRNA-mediated knockdown of FHOD1 expression
(FHOD1-i), we found that AurB–Venus localisation to
protrusions of spreading cells was either abolished (52/90 cells
from three separate experiments) or attenuated (#14 minutes in
16/90 cells; Fig. 3B; supplementary material Movies 7, 8).
Cortical localisation of AurB was partially rescued by co-
transfection of siRNA-resistant RFP-FHOD1 (supplementary
material Fig. S3). We also found that localisation of
endogenous AurB to the cell periphery in early G1 phase was
abolished in FHOD1-i, and rescued by siRNA-resistant FHOD1
(supplementary material Fig. S3). We concluded that FHOD1 is
required to maintain a pool of AurB at the cell cortex in early G1
phase.
FHOD1 coordinates MT and actin cytoskeletons during
cell spreading
We next examined whether FHOD1 was required for cell
spreading in RPE-a-actinin–Venus cells and found pronounced
effects on cell shape in FHOD1-i cells after mitosis. Cells spread
rapidly but did not do so in correctly polarized fashion,
displaying multiple sites of sustained cortical ruffling in early
G1 phase (Fig. 3C; supplementary material Movie 9) and, as in
Cdh1-i cells, failure to develop a leading edge or to adopt the
elongated shape typical of RPE cells (Fig. 3D). We also
examined the distribution of F-actin in paraformaldehyde
(PFA)-fixed populations of U2OS cells by phalloidin staining,
observing in FHOD1-i-treated cells an absence of the robust
peripheral actin cables characteristic of control post-mitotic cells
(Fig. 3E, see also Fig. 4D). The absence of these cortical actin
cables was directly related to loss of cell shape (Fig. 3F). Since
cell shape and polarity are generally defined by cues delivered by
MTs, we examined the MT network in methanol-fixed
populations of U2OS cells and found that the density and
organization of the MT network in early G1 cells was reduced
after FHOD1-i (Fig. 3G). We noted the absence of MTs oriented
along the long axis of the cell and that are required to drive cell
elongation (Picone et al., 2010). This population of MTs could be
rescued by co-expression of siRNA-resistant HA–FHOD1wt,
along with rescue of cell shape (Fig. 3G,H). A version of HA–
FHOD1 lacking the FH2 domain (shown to mediate MT
stabilization in related formin mDia2) (Bartolini et al., 2008)
was not able to rescue (Fig. 3G,H). We then stained U2OS and
RPE cells with MT plus-end (+TIP) marker EB3, to examine the
presence of +TIPs at the cell cortex. We found that the number of
EB3 comets close to the cell cortex was reduced in FHOD1-i
(Fig. 3I; supplementary material Fig. S3), consistent with a role
for FHOD1 in promoting MT growth to the cell cortex in early
G1 cells. In the same experiment we found the density of EB3
comets close to the cortex was increased after treatment of cells
with ZM, indicating that AurB activity at this time would
generally act to suppress MT growth at the cortex. AurB is
known to selectively destabilize MTs at incorrectly attached
kinetochores, earlier in mitosis, through recruitment of the
kinesin-13 MCAK (Cimini et al., 2006; Knowlton et al., 2006)
and MCAK localised to +TIPs close to the cell cortex in early G1
cells (data not shown). We thus propose that AurB and FHOD1
contribute respectively to the selective destabilization and
stabilization of MTs required to establish a polarised network
in early G1 phase.
AurB controls cell spreading through FHOD1
Finally, we investigated whether FHOD1 is a downstream target
of AurB in regulating cell spreading. AurB-dependent
phosphorylation (RphosSL, AurB consensus sequence) of
FHOD1 had previously been reported (Ozlu¨ et al., 2010). To
identify AurB phosphorylation sites in FHOD1 we subjected in
vitro-phosphorylated full-length FHOD1 to mass spectrometry
(supplementary material Fig. S4). Multiple AurB
phosphorylation targets were identified in FHOD1 including
Ser367 as initially reported (Ozlu¨ et al., 2010) and an additional
cluster of four phospho-Ser/Thr residues (between 486 and 498)
within the coiled-coil domain that lies just upstream of the
conserved FH1 and FH2 domains (Fig. 4A). Since a recent
proteomic study confirms that this phosphorylation cluster is
present on FHOD1 in mitotic cells (Kettenbach et al., 2011) and
these four sites together with Ser367 comprise the large majority
of all AurB phospho-sites in FHOD1 (supplementary material
Fig. S4), we mutated these five residues to generate phospho-
mimetic (FHOD1-5D) or non-phosphorylatable (FHOD1-5A)
versions of FHOD1. Expression and immuno-isolation of HA-
tagged versions of FHOD1 from human cells confirmed that
these five sites (S367, S486, T489, T495, S498) contribute
significantly to phosphorylation of FHOD1 by AurB in vitro
(Fig. 4B,C). To investigate the role of FHOD1 phosphorylation
by AurB in cell spreading we carried out siRNA-rescue
experiments using the 5D and 5A versions of HA–FHOD1. We
used PFA-fixed populations of cells, to examine together actin
and MT cytoskeletons and HA–FHOD1 localisation, and MEOH
fixation to examine AurB localisation at the cell cortex. We
found that AurB recruitment to the cortex was not affected by our
phospho-site mutations in FHOD1 (supplementary material Fig.
S3). However, we found clear differences in organization of the
peripheral cytoskeleton between cells rescued with phospho-
mimetic and non-phosphorylatable versions of HA–FHOD1
Table 1. Statistical analysis of AurB–Venus localisation data shown in Fig. 2A
Treatment
First appearance
(minutes after anaphase) Duration (minutes)
P-value versus untreated
(Student’s t-test)
Number of cells
analysed
Number of cells with
no AurB at cell edge
Untreated 15.063.4 3369.2 20 2
MG132 16.862.9 87621* ,0.0001 14 0
Nocodazole 24.7613.6 6.763.1 ,0.01 15 12
ZM447439 19.567.4 1366.8 ,0.0001 14 6
Cytochalasin D 18.564.7 66625* ,0.0001 15 0
*Underestimate.
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(Fig. 4D–G). Examination of cells rescued with wild-type HA–
FHOD1 revealed, as expected, assembly of peripheral actin SFs
in early G1 phase, closely aligned with MTs oriented along the
cortex (Fig. 4D left-hand panels, compare HA-positive cell with
adjacent non-rescued cell in early G1 phase). We also noted that
HA–FHOD1wt itself showed colocalisation with peripheral actin
SFs/MTs, and additionally localised to the tips of some MTs at
the leading edges of the cell (Fig. 4D,F). The phospho-mimetic
HA–FHOD1-5D was able to rescue the assembly of robust
peripheral SFs in early G1 phase and showed similar localisation
Fig. 3. See next page for legend.
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to FHOD1wt, predominantly at sites of colocalisation of MTs
with SFs (Fig. 4D–F). HA–FHOD1-5A was less efficient in
rescue of SFs and showed a different pattern of localisation.
Peripheral SFs were significantly weaker, and polymerized actin
was frequently seen extending beyond the MT bundles that
usually define the cell edge (Fig. 4D,E). HA–FHOD1-5A, like
HA–FHOD1DFH2, also showed a reduced tendency to localise
with MTs but was observed to colocalise with F-actin along the
cell boundaries (Fig. 4D,F). This suggests that AurB-mediated
phosphorylation of FHOD1 is required to coordinate the
assembly of F-actin fibres with stable oriented MTs at the cell
periphery in early G1 phase.
Discussion
We identified a pool of AurB recruited at the cell cortex in early
G1 phase that, in contrast to other pools of AurB that undergo
phosphatase-mediated inactivation (Steigemann et al., 2009;
Wurzenberger et al., 2012) relies exclusively on APC/C-
mediated proteolysis for its inactivation at mitotic exit. APC/
CCdh1 is required to eliminate most of this pool of AurB,
restricting it to protrusions associated with cell spreading and
thereby exerting spatial control on the activity of the kinase. We
have observed that the duration and size of this pool are sensitive
to the surface on which AurB–Venus cells are cultured (N.W. and
C.L., unpublished observations) leading us to speculate that AurB
could modulate responses to external cues. We are currently
working to establish an in vivo degradation assay for AurB that
will allow us to test whether the rate or timing of AurB
proteolysis by APC/CCdh1 is influenced by parameters affecting
cell adhesion after division.
We further identified the formin FHOD1, a known C-phase-
specific binding partner (Ozlu¨ et al., 2010), as an essential factor
in retaining AurB at the cell cortex. FHOD1 has previously been
shown to be an effector of Rac1, with expression of a
constitutively active version shown to induce SF assembly, to
promote alignment of MTs with SFs, and to enhance cell
elongation and migration (Gasteier et al., 2003; Gasteier et al.,
2005; Koka et al., 2003). Consistent with this we find phenotypes
in FHOD1-knockdown daughter cells that include loss of cell
shape and misaligned MTs and SFs, suggesting that FHOD1
plays a specific role in the dynamic interplay between MT and
actin cytoskeletons that is required to remodel the shape and
polarity of newly divided cells. Our work demonstrates that
spatial control of AurB kinase activity by APC/CCdh1 is critical to
this remodelling through regulation of targets that include
FHOD1. Absence of AurB from the cortex (in FHOD1-i), or
else over-recruitment of AurB at the cortex (in Cdh1-i) both lead
to loss of cell shape. Therefore we propose that correct cell shape
is achieved through stabilization of selected MTs in a manner
depending on tightly regulated localisation of AurB. In this
scenario, we envision that AurB triggers FHOD1 activity by at
least two distinct mechanisms. First, FHOD1 subcellular
localisation and activity are regulated by Rac1 (Gasteier et al.,
2003; Koka et al., 2003; Westendorf, 2001) and since AurB is an
upstream regulator of Rac1 (Bastos et al., 2012; Minoshima et al.,
2003), the kinase may indirectly activate FHOD1 via Rac1.
Second, we find that a cluster of phosphorylation sites upstream
of the FH1 and FH2 domains is phosphorylated by AurB in vitro,
and that a non-phosphorylatable version of this cluster interferes
with the function of FHOD1 in coordinating SF assembly with
oriented MTs. We propose that, as in regulation of FHOD1 by
ROCK (Hannemann et al., 2008; Takeya et al., 2008),
phosphorylation of the DRF by AurB may directly induce
conformational changes and/or allow for additional protein
interactions. Given the position of AurB phosphorylation sites
in FHOD1 near the coiled-coil domain that governs
multimerization of the DRF (Madrid et al., 2005), these
modifications are likely to affect multimerization rather then
autoinhibition of FHOD1. Based on preliminary results
indicating decreased multimerization of FHOD1-5D (data not
shown), it is tempting to speculate that AurB mediated
phosphorylation results in monomeric FHOD1 that is
particularly prone to stabilize MTs while FHOD1 without AurB
phosphorylation persists as multimer and exclusively acts on
actin organization. Further work is required to test this hypothesis
and determine the precise properties of FHOD1 regulated by
AurB in MT stabilization or actin nucleation.
In our model, active FHOD1 would stabilize a selected
population of MTs in FH2 domain-dependent manner, and direct
oriented SF assembly at the cell periphery, activities promoted by
AurB delivered to the cortex on FHOD1-stabilized MTs (Fig. 5).
Our finding that global inhibition of AurB by the kinase inhibitor
ZM promoted the appearance of MT plus-ends close to the cell
edge suggests, however, that AurB would play a role in
destabilizing other MTs at this time in the cell cycle. We
reconcile these findings by proposing that alternative binding
partners of AurB control distinct populations of MTs. In this
model AurB delivered at the cell cortex would either contribute
to MT destabilization or, through recruitment by FHOD, to
stabilization of selected MTs. APC/CCdh1 would act to restrict the
Fig. 3. FHOD1 controls AurB localisation and cell spreading during
return to interphase. (A) AurB–Venus-expressing cells were transfected
with HA-tagged FHOD1, fixed and stained after 24 hours with antibodies
against FHOD1 and GFP (left-hand panel) or HA and AurB (middle panel).
Other cells were treated briefly with MG132 (as in Fig. 1A) and stained for
pAur and HA (right-hand panel). Arrows indicate some sites of colocalisation.
Scale bars: 10 mm. (B) Individual cell trajectories from populations of AurB–
Venus cells treated with control or FHOD1 siRNA (supplementary material
Movies 7, 8). See also supplementary material Fig. S3. (C) Frames from
representative movies of RPE-a-actinin–Venus cells filmed as in Fig. 2C after
treatment with control or FHOD1 siRNA. Scale bars: 20 mm. (D) Time-lapse
movies of FHOD1-i RPE-a-actinin–Venus cells were used to calculate cell
shape indices as described for Fig. 2E. Gl2-i and Cdh1-i results from Fig. 2E
are included for comparison. (E–I) U2OS cells synchronized and fixed to
optimize staining for F-actin (using phalloidin), for MTs (b-tubulin) or for
MT +TIPS (EB3). Cells were treated with control or FHOD1 siRNA, or
FHOD1-i together with siRNA-resistant versions of HA-FHOD1 where
indicated. Representative images are shown in E, G and I. (F) Values for
relative F-actin staining at the cortex in individual cells were calculated as the
ratio of maximum value at the cell periphery to average pixel value across the
cell (as described in more detail in legend to Fig. 4E) and are plotted here
against the circularity measurement for each cell, measured as described in
legend to Fig. 3H. Trend line indicates the inverse relationship between
peripheral F-actin staining and cell shape. (H) Cell shape measurements were
made from images of 40 or more cells acquired from two separate
experiments. Circularity is measured on a scale of 0–1, where 1 represents a
perfect circle (see Materials and Methods for details). ***P,0.0001 by
Student’s t-test. (I) Representative images of cells stained for EB3. ZM was
added 15 minutes prior to fixation, where indicated. Images of the boxed
regions show regions of the cell edge under increased magnification and
contrast, all pixels were treated in an identical fashion. See also
supplementary material Fig. S3. Scale bars: 5 mm.
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Fig. 4. FHOD1 phosphorylation by AurB coordinates F-actin assembly. (A) Schematic of FHOD1 domain organization showing known functional domains
and AurB phosphorylation sites identified by mass spectrometry. Further details are in supplementary material Fig. S4. S/T residues in bold were mutated to
generate FHOD1-5D and 25A. GBD, GTPase binding domain; DAD, Dia autoregulatory domain; FH, formin homology. (B) In vitro kinase assay comparing
HA–FHOD1wt with HA–FHOD1-5A after immuno-isolation from HEK293T cells and in vitro kinase reaction with recombinant AurB. The upper panel
depicts an autoradiograph of the kinase reaction, the lower panel an immunoblot to illustrate the amounts of FHOD1 protein in each kinase reaction.
(C) Quantification of the FHOD1 phosphorylation shown in B. Depicted is the ratio of the phospho-FHOD1 relative to total FHOD1 protein signal, normalized to
the values obtained for FHOD1wt (mean of three independent experiments 6 s.d.). (D–G) U2OS cells were prepared by FHOD1 siRNA-rescue to express
different versions of HA–FHOD1, synchronized in early G1 phase and fixed with PFA. (D) Representative images of cells examined for the presence of F-actin,
MTs and HA. Arrows indicate prominent F-actin cables at the periphery of daughter cells. Arrowheads in enlarged images indicate sites of colocalisation of labels.
Scale bars: 20 mm. (E) F-actin staining was profiled along a cell section (indicated by yellow arrow, left-hand panel) bisecting the direction of maximum spread of
daughter cells. Relative staining at the cortex was calculated as the ratio of the maximum value at the cell periphery to average pixel value across the cell.
The distribution of data collected from more than 40 cells from two experiments are shown as box-plots. ***P,0.001, *P,0.01 by Student’s t-test. (F) Cells from
the same experiments were scored for colocalisation of HA–FHOD1 with MTs or SFs at the cell cortex. Bar chart shows percentage of the total number of
HA-positive cells examined in different categories. (G) Cell shape analysis was carried out as in Fig. 3G. **P,0.001, *P,0.01 by Student’s t-test.
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pool of AurB activity close to or at the cell cortex to promote
polarized cell shape (Fig. 5).
A central role of AurB activity in polarizing events involving
both MTs and actin has previously been described during
monopolar cytokinesis (Hu et al., 2008), events that we have
also found to depend upon FHOD1 (C.M., M.M. and C.L.,
unpublished data). Coordination of MT and F-actin networks
may thus emerge as a central biological property of FHOD1.
Understanding further how these components interact with each
other both physically and functionally will be critical to
understanding how daughter cell identity is established at the
beginning of interphase.
Materials and Methods
Plasmids
pTRE-AurB-Venus was made from Aurora B-GFP (kind gift of YL Wang).
pEGFP-N1-a-actinin1 (Edlund et al., 2001) was obtained from Addgene and GFP
swapped for Venus fluorescent protein to make pVenus-N1-a-actinin. Expression
plasmids for HA-FHOD1, HA-FHOD1DFH2 were previously described (Gasteier
et al., 2003). Expression plasmids for FHOD1-RFP, siRNA-resistant FHOD1
versions, and FHOD1-5D and -5A point mutants were made using standard cloning
and site directed mutagenesis techniques and verified by sequencing. Full cloning
details for all constructs available on request.
Cell culture, synchronization and transfection
HeLa cells were cultured in high glucose DMEM (Invitrogen, Carlsbad, CA,
USA). hTERT-RPE1 (RPE) cells were cultured in 50:50 mix of Ham’s
F12:DMEM (Sigma-Aldrich, St. Louis, MO, USA). U2OS cells were cultured in
50:50 mix of Leibovitz L15:DMEM. All cell culture media were supplemented
with FBS (10%), penicillin–streptomycin and amphotericin B (all from PAA
Laboratories, Pasching, Austria). U2OS tet-OFF cell culture medium was
additionally supplemented with 500 mg/ml geneticin (PAA) and 1 mg/ml
tetracycline hydrochloride (Calbiochem, San Diego, CA, USA).
RPE-a-actinin–Venus cells were made by clonal selection with 500 mg/ml
geneticin of cell populations transfected with pVenus-N1-a-actinin-Venus. U2OS-
AurB–Venus cells were obtained by clonal selection with 170 mg/ml hygromycin
B (Calbiochem) after transfection of U2OS tet-OFF cells with pTRE-AurB-
Venus:pCMVhygro in a ratio of 10:1.
HeLa and U2OS cells were synchronized in early G1 phase by release for
13 hours from thymidine/aphidicolin double block. RPE cells were synchronized
in early G1 phase by 16 hour release from single thymidine block.
siRNA duplexes targeting sequences in hsCdh1 and hsFHOD1 as previously
described (Floyd et al., 2008; Hannemann et al., 2008), and control siRNA duplex
against GL2, were obtained from Ambion (Austin, TX, USA).
Transfections were carried out using LipofectamineH 2000 or OligofectamineH
(Invitrogen). siRNA-rescue experiments were achieved by electroporation using
Invitrogen NeonH system to electroporate cells with mixtures of siRNA and
siRNA-resistant plasmid, according to the manufacturers’ instructions. Cells were
analysed 44–48 hours following transfection/electroporation.
Immunofluorescence analysis
Cells were grown on 12 mm glass coverslips, synchronized and fixed using either
100% methanol at 220 C˚ or 4% PFA treatment at ambient temperature. Full
details of buffers, reagents and antibodies used are given in supplementary
material Table S1. Widefield images were captured on an Olympus CellR platform
(Fig. 1C; Fig. 3A; supplementary material Fig. S1; see description in next section)
or an inverted Zeiss Axiovert 200M microscope with 6361.3 NA oil objective and
CoolSNAP HQ camera (Photometrics, Tucson AZ, USA), running MetamorphH
software (Molecular Devices, Sunnyvale, CA, USA; Fig. 1A,E; Fig. 3E,G;
Fig. 4D). Confocal images were captured using a TCS SP5 Confocal Leica laser
scanning microscope equipped with a DMI60000 microscope and a HCX PL APO
Lambda blue 6361.4 NA oil objective (Fig. 3I; supplementary material Fig. S3).
Intensity level, contrast and brightness of images were adjusted using Adobe
Photoshop where indicated.
Pixel quantifications (Fig. 1G; Fig. 3F; Fig. 4E) were carried out in ImageJ,
using 16-bit images acquired on widefield microscopes. Circularity calculations
(Fig. 3H; Fig. 4G) were carried out in ImageJ, using the equation:
circularity54p(area/perimeter2).
Time-lapse microscopy
Cells were seeded onto 8-well plastic-bottom slides (Ibidi GmbH, Martinsried,
Germany) for time-lapse analyses. For both AurB–Venus and a-actinin–Venus
experiments cells were seeded at 86104 cm22. Imaging medium was L-15
supplemented with FBS and antibiotics as described above. Expression of AurB–
Venus was induced 24 hours prior to filming, and cells chosen for time-lapse
recording according to the presence of a Venus-positive metaphase plate. Dishes
were used up to 30 hours after induction, after which AurB–Venus levels were
deemed too high (and mitotic aberrations were frequently observed). All time-
lapse imaging was carried out on an Olympus CellR imaging platform comprised
of Olympus IX81 motorized inverted microscope, Orca CCD camera (Hamamatsu
Photonics, Japan), motorized stage (Prior Scientific, Cambridge, UK) and 37 C˚
incubation chamber (Solent Scientific, Segensworth, UK). Cells were imaged by
epifluorescence and DIC microscopy, using appropriate filter sets to record AurB–
Venus localisation and a-actinin distribution, using 4061.3 NA oil and 6061.42
NA oil objectives, respectively. Movies were recorded using Olympus CellR
software, as 1 mm stacks of up to 12 fields per experiment, acquired at 2 minute
intervals and with 262 bin to minimize bleaching. All movies and movie frames
are displayed as maximal projections of stacks. Image sequences were analysed
using CellR software or else exported as 12-bit tiff files for analysis in ImageJ.
Drug treatments
Cells were subjected to different drug treatments during time-lapse experiments,
by addition of drug in a volume not less than 1/100 of the existing dish volume and
gentle mixing of medium on the dish using a 1 ml Gilson pipette. Drugs were used
at the following final concentrations: MG132 (Tocris Bioscience, Bristol, UK)
4 mM; ZM447439 (Tocris Bioscience) 10 mM; nocodazole (Sigma-Aldrich) 2 mM;
taxol (Tocris Bioscience) 5 mM; cytochalasin D (Sigma-Aldrich) 1 mM.
Fig. 5. Proposed model for cell shape control during mitotic exit. Timescales for proposed sequence of events are shown as minutes after anaphase.
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In vitro kinase assays
To assay for phosphorylation by AurB, wt or mutant HA-FHOD1 variants were
expressed in HEK293T cells. Following lysis in ROCK lysis buffer [10 mM Tris-
HCl, pH 7.5; 40 mM Na4P2O7N10H2O; 5 mM EDTA; 150 mM NaCl; 1% (v/v)
NP-40; 0.5% (v/v) sodium deoxycholate; 0.025% (v/v) SDS; 1:1000 protease
inhibitor cocktail (Roche)], FHOD1 proteins were immuno-isolated with anti-HA
antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA) coupled to protein-G–
Sepharose (GE Healthcare, Little Chalfont, UK). After intensive washing in lysis
buffer, immunoprecipitates were subjected to kinase reactions in 30 ml kinase
assay buffer (5 mM MOPS, pH 7.2; 2.5 mM b-glycerophosphate; 1 mM EGTA;
0.4 mM EDTA; 5 mM MgCl2; 0.5 mM DTT; 1 mM ATP), supplemented with
4 mCi [c-32P]ATP and with 1 ml recombinant active GST-AurB (Sigma Aldrich)
and incubated at 30 C˚ for 90 minutes. The kinase reaction was inhibited with
specific AurB inhibitor ZM447439 or Staurosporine (Sigma Aldrich) where
indicated.
For mass spectrometry, the assay was conducted with wild-type full length
recombinant FHOD1 [kind gift from Matthias Geyer (Hannemann et al., 2008)]
with non-radioactive ATP and 30 minutes incubation at 30 C˚. Samples were run
on an SDS-polyacrylamide gel and stained with Coomassie Brilliant Blue G-250.
Mass spectrometry
For sample preparation, protein bands were manually excised from the gel and
tryptic in-gel-digest performed based on the protocol from Rosenfeld (http://www.
ncbi.nlm.nih.gov/pubmed/1524213) using modified porcine trypsin, sequencing
grade, from Promega (Madison, WI, USA). The collected peptide samples were
dried and dissolved in 3% acetonitrile and 0.1% formic acid.
For LC-MS/MS, peptides were separated using a nanoAcquity ultra performance
liquid chromatography (UPLC) system (Waters Corporation, Milford, MA, USA)
fitted with a trapping (nanoAcquity Symmetry C18.5 mm, 180 mm620 mm) and
an analytical column (nanoAcquity BEH C18, 1.7 mm, 75 mm6200 mm). The
outlet of the analytical column was coupled directly to a linear trap quadrupole
(LTQ) Orbitrap Velos (Thermo Fisher Scientific, Waltham, MA, USA). Peptides
were eluted through the analytical column at a constant flow of 0.3 ml/minute and
total runtime 45 minutes. Full scan mass spectrometry spectra with mass range
200–2.000 mass-to-charge ratio (m/z) were acquired in profile mode in the
Orbitrap with resolution of 30.000. The most intense ions (up to 15) from the full-
scan mass spectrometry were selected for fragmentation in the LTQ. Neutral loss
masses for phosphorylations were screened and selected for further fragmentation
if present and the multistage activation was enabled.
The raw data were processed using MaxQuant (version 1.0.13.13) (Cox and
Mann, 2008), and MS/MS spectra were searched using the Mascot search engine
(version 2.2.07, Matrix Science) against a Swissprot database (download
11.07.2012) restricted to human entries, with a maximum of one missed cleavage
allowed. Carbamidomethylation was set as fixed modification while methionine
oxidation and phosphorylation on S and T were included as variable modifications.
The search was performed with an initial mass tolerance of 5 ppm for the precursor
ion and 0.5 Da for the MS/MS spectra and a minimum ion score of 20 was applied.
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